Under Dr. Gottlieb, CDRH continued bringing innovative devices to market using a total product life-cycle approach. For example, expanded approval of an automated insulin dosing system for people age 7 and up with diabetes and the world ’ s smallest heart valve for newborns.pic.twitter.com/SNokx8QVXW
Under Dr. Gottlieb, CDRH continued bringing innovative devices to market using a total product life-cycle approach. For example, expanded approval of an automated insulin dosing system for people age 7 and up with diabetes and the world’s smallest heart valve for newborns. pic.twitter.com/SNokx8QVXW
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news
More News: Cardiology | Diabetes | Endocrinology | Heart | Heart Valve Disease | Heart Valves | Insulin | Medical Devices